Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
210.78
129.01
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
210.78
129.01
0.00
0.00
0.00
0.00
Raw Material Cost
3.77
2.84
1.90
1.12
0.33
0.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
38.47
32.29
28.74
14.08
5.24
3.50
Other Expenses
12.15
9.70
6.66
3.59
2.11
0.82
Total Expenditure (Excl Depreciation)
163.77
132.18
97.25
51.13
26.67
11.82
Operating Profit (PBDIT) excl Other Income
47
-3.2
-97.2
-51.1
-26.7
-11.799999999999999
Other Income
19.47
15.22
2.63
-0.03
0.14
0.45
Operating Profit (PBDIT)
70.26
14.90
-92.72
-50.04
-26.20
-11.27
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
6.27
Gross Profit (PBDT)
207.01
126.17
-1.90
-1.12
-0.33
-0.10
Depreciation
3.77
2.84
1.90
1.12
0.33
0.10
Profit Before Tax
66.48
12.06
-94.62
-51.16
-26.52
-5.10
Tax
0.86
18.74
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
65.63
-6.68
-94.62
-51.16
-26.52
-5.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
65.63
-6.68
-94.62
-51.16
-26.52
-5.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
65.63
-6.68
-94.62
-51.16
-26.52
-5.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
428.68
242.36
212.55
298.72
-41.49
-15.52
Earnings per share (EPS)
1.68
-0.2
-3.02
-1.64
-0.85
-0.16
Diluted Earnings per share
1.68
-0.2
-3.02
-1.64
-0.85
-0.16
Operating Profit Margin (Excl OI)
22.3%
-2.45%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
33.33%
11.55%
0.0%
0.0%
0.0%
0.0%
PAT Margin
31.13%
-5.18%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 63.41% vs 0.00% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 1,079.10% vs 92.92% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 17,033.33% vs 99.69% in Dec 2023
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Entrada Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
210.78
0.04
210.74
526,850.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
210.78
0.04
210.74
526,850.00%
Raw Material Cost
3.77
6.71
-2.94
-43.82%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
38.47
39.87
-1.40
-3.51%
Other Expenses
12.15
14.13
-1.98
-14.01%
Total Expenditure (Excl Depreciation)
163.77
187.88
-24.11
-12.83%
Operating Profit (PBDIT) excl Other Income
47.01
-187.84
234.85
125.03%
Other Income
19.47
27.01
-7.54
-27.92%
Operating Profit (PBDIT)
70.26
-154.12
224.38
145.59%
Interest
0.00
0.00
0.00
Exceptional Items
0.00
-0.04
0.04
100.00%
Gross Profit (PBDT)
207.01
-6.67
213.68
3,203.60%
Depreciation
3.77
6.71
-2.94
-43.82%
Profit Before Tax
66.48
-160.87
227.35
141.33%
Tax
0.86
0.00
0.86
Provisions and contingencies
0
0
0.00
Profit After Tax
65.63
-160.87
226.50
140.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
65.63
-160.87
226.50
140.80%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
65.63
-160.87
226.50
140.80%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
428.68
510.61
-81.93
-16.05%
Earnings per share (EPS)
1.68
-2.98
4.66
156.38%
Diluted Earnings per share
1.68
-2.98
4.66
156.38%
Operating Profit Margin (Excl OI)
22.30%
-507,678.38%
0.00
507,700.68%
Gross Profit Margin
33.33%
-416,656.76%
0.00
416,690.09%
PAT Margin
31.13%
-434,778.38%
0.00
434,809.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 21.08 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 63.41% vs 0.00% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 6.56 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 1,079.10% vs 92.92% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.08 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 17,033.33% vs 99.69% in Dec 2023
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.30%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
